National Center for Advancing Translational Sciences in North Carolina
National Center for Advancing Translational Sciences (93.350) awarded $208 million to recipients in North Carolina in 56 grants from fiscal 2021 to 2025, 6.7% of the program's national total. Duke University received the most, $88.9 million.
- Awarded in North Carolina$208 million
- Awards56
- Share of the program6.7%
- Rank among states4th of 41
- National total$3.1 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 19 | $77.6 million |
| FY 2022 | 23 | $39.9 million |
| FY 2023 | 27 | $36.1 million |
| FY 2024 | 17 | $22.6 million |
| FY 2025 | 18 | $31.4 million |
Recipients in North Carolina
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Duke University | Colleges and universities | 11 | $88.9 million |
| University of North Carolina at Chapel Hill | Colleges and universities | 16 | $74.5 million |
| Wake Forest University Health Sciences | Colleges and universities | 8 | $25.3 million |
| Altis Biosystems, Inc. | Small businesses | 4 | $4.4 million |
| Phase, Inc. | Small businesses | 2 | $2.1 million |
| Epicypher, Inc. | Small businesses | 1 | $2.1 million |
| Adamas Nanotechnologies, Inc. | Small businesses | 1 | $2.0 million |
| Eldec Pharmaceuticals, Inc. | Small businesses | 1 | $2.0 million |
| Simulations Plus Inc | Businesses | 1 | $1.7 million |
| Gateway Bio Inc | Small businesses | 1 | $1.3 million |
Open opportunities under this program
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed)
- Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
- Clinical and Translational Science Award (UM1 Clinical Trial Optional)
- Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional)
See all 34 on the program page
Questions people ask
How much National Center for Advancing Translational Sciences money goes to North Carolina?
$208 million from fiscal 2021 to 2025, across 56 awards. North Carolina ranks 4th of 41 states and territories for this program.
Who receives National Center for Advancing Translational Sciences money in North Carolina?
The largest recipient is Duke University, with $88.9 million in 11 awards. Next are University of North Carolina at Chapel Hill and Wake Forest University Health Sciences.
Can organizations in North Carolina apply now?
Yes, 34 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
National Center for Advancing Translational Sciences in other states
Other large programs in North Carolina
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Children's Health Insurance Program
- USAID Foreign Assistance for Programs Overseas
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- Special Education Grants to States